Strata Critical Medical Q1 revenue up 87% to $67.4M; net income $2.4M vs prior loss

Strata Critical Medical, Inc.

2026-Q1 EPS reported $0.03 revenue$67,384,000

Revenue $67.4M (up 87.4% YoY); net income from cont. ops $2.4M vs loss of $1.6M YoY.
Adjusted EBITDA $6.4M; gross margin improved to 21.0% from 19.6%.
Logistics revenue up 32.4% to $47.6M; Clinical segment contributed $19.8M (new).
Completed bolt-on acquisition of Ohio Valley Perfusion Associates; reiterating full-year 2026 guidance.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Strata Critical Medical, Inc. updated its first quarter ended March 31, 2026 guidance (reaffirmed).

Period: first quarter ended March 31, 2026
Guidance: reaffirmed
Result: reported results

Exact text from the filing

On May 6, 2026, Strata Critical Medical, Inc. (“Strata”) issued a press release announcing its financial results for the first quarter ended March 31, 2026.

View on SEC.gov

Browse all earnings releases →

Strata Critical Medical, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-030898

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.